Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Exercise × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 21 Motor Activity 13 Carcinoma, Non-Small-Cell Lung 11 Neoplasms 3 Gastrointestinal Neoplasms 2 Fatigue 2 Breast Neoplasms 2 Weight Loss 1 Vomiting 1 Urogenital Neoplasms 1 Small Cell Lung Carcinoma 1 Sedentary Behavior 1 Rehabilitation After Lung Cancer Surgery 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nausea 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma 1 Lung Cancer Patients 1 Inflammation 1 Health Education 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Cachexia 1 Adenocarcinoma of Lung 1

Interventions

Etoposide 152 Carboplatin 141 Cisplatin 101 Topotecan 76 durvalumab 52 atezolizumab 50 Irinotecan 45 pembrolizumab 38 Paclitaxel 34 Nivolumab 33 Radiotherapy 31 PM 01183 24 Drug Therapy 23 anlotinib 21 Gemcitabine 21 apatinib 19 Ipilimumab 18 Docetaxel 17 Temozolomide 16 Platinum 16 Radiosurgery 15 Pemetrexed 14 tislelizumab 13 olaparib 13 Magnetic Resonance Spectroscopy 13 Bevacizumab 13 toripalimab 11 rovalpituzumab tesirine 11 amrubicin 11 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01881906 2018-09-06

EXHALE

Rigshospitalet, Denmark

Phase NA Completed

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡